Reaching patients in over 70 Countries

In order to deliver our products quickly and efficiently, we established Japan as a base for research and implemented a system of simultaneous development in Japan, the US, Europe, and Asia. As a global pharmaceutical company, we are currently working in over 70 countries, and are establishing footholds in each market as we continue to expand.
 

Reaching patients in over 70 Countries


Focusing on Innovative Drug Discoveries for Sustainable Development

Focusing on Innovative Drug Discoveries for Sustainable Development_1

 

 (For the year ended March 2021)